Fresh analysis suggests that patients who stop using popular weight-loss injections like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who end traditional lifestyle regimens.
Published data in a leading health publication demonstrates that while obese individuals can lose a large proportion of their body weight while using the jabs, the weight comes back at an average rate of 0.8 kg per month once they quit.
"Users buying these treatments must be aware of the danger of rapid rebound weight gain when the treatment is stopped," warns researcher Dr. Susan Jebb.
That rate of recovery implies a reversion to original mass within about a year and a half.
Comparing Approaches
The research, which reviewed dozens of trials involving over 9,000 of participants, compared the outcomes of the injectable medications with other pills.
Scientists note that people who shed pounds through lifestyle changes alone usually experience a slower weight regain—perhaps 100 grams monthly—once they finish.
Understanding the Fast Rebound
Nutrition scientists suggest the mode of action of the jabs is key to understanding the accelerated weight return.
The injections copy a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Artificially providing GLP-1 concentrations several times higher than normal could lead to the system to generate a reduced amount of its endogenous hormone, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication leads to appetite is unsuppressed, making overeating much more probable."
A Lifelong Issue?
Medical guidelines recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians argue that, due to the likelihood of relapse, the treatment is often ongoing.
This view is reinforced by drug manufacturers, who say that the results "emphasize the persistent character of obesity," comparing it to managing diseases like diabetes.
Patient Testimonies
Individuals who have come off the jabs explain a powerful return of cravings.
"It was like a trigger flipping and you become ravenous," described one woman.
This difficulty is exacerbated if individuals have not established permanent lifestyle or habit changes during therapy.
Significant Interest
Survey data indicate that millions of adults in the UK have used these injections in the last 12 months, with interest being substantial.
- Adoption is greater among females compared to males.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than the NHS.
Finally, clinicians stress that while these medications are effective tools for shedding pounds, they are not a standalone fix and maintained weight loss likely depends on ongoing lifestyle support.
